Why the study?
Does transcatheter aortic-valve replacement improve survival at 1 year in high-risk patients with severe aortic stenosis compared to surgical aortic-valve replacement?
Does transcatheter aortic-valve replacement improve survival at 1 year in high-risk patients with severe aortic stenosis compared to surgical aortic-valve replacement?
Transcatheter and surgical aortic-valve replacement provide similar 1-year survival in high-risk patients with severe aortic stenosis.
Answers are grounded in this paper and cite their sources.
Supports TAVR as alternative for high-risk severe aortic stenosis; extends randomized evidence for less invasive valve replacement.
In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aortic-valve replacement were associated with similar rates of survival at 1 year, although there were important differences in periprocedural risks. (Funded by Edwards Lifesciences; Clinical Trials.gov number, NCT00530894.).
No takes yet. Share an insight, caveat, or question.
Smith et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: